- ByInvesting.com-
Enanta Pharmaceuticals (NASDAQ: NASDAQ:ENTA), a biopharmaceutical company focused on developing oral therapeutics, reported its financial results for the fiscal second quarter...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
176.91 | 178.35 | 176.13 | -1.44 | -0.81% | 2.82M | ||
162.82 | 163.14 | 162.02 | +0.52 | +0.32% | 2.49M | ||
347.92 | 348.53 | 343.39 | +5.82 | +1.70% | 771.65K | ||
31.11 | 31.45 | 31.03 | +0.14 | +0.44% | 19.1M | ||
412.12 | 414.60 | 411.42 | -1.42 | -0.34% | 7.06M | ||
104.67 | 107.88 | 104.21 | -11.80 | -10.13% | 39.13M | ||
57.65 | 57.73 | 57.37 | +0.31 | +0.53% | 1.4M | ||
47.16 | 47.46 | 47.01 | +0.05 | +0.11% | 5.99M | ||
444.25 | 447.40 | 443.47 | +0.58 | +0.13% | 814.88K | ||
192.50 | 192.93 | 191.63 | +0.50 | +0.26% | 3.78M | ||
62.38 | 62.82 | 62.27 | +0.04 | +0.06% | 4M | ||
268.37 | 270.67 | 268.17 | -0.93 | -0.35% | 1.11M | ||
128.90 | 128.91 | 127.08 | +1.33 | +1.04% | 2.49M | ||
96.23 | 97.09 | 96.04 | -0.36 | -0.37% | 1.61M | ||
182.13 | 184.90 | 181.32 | +0.43 | +0.23% | 46.11M | ||
188.98 | 189.94 | 188.11 | +0.28 | +0.15% | 18.22M | ||
299.47 | 302.91 | 299.08 | -0.01 | 0.00% | 1.12M | ||
60.47 | 60.80 | 60.05 | +0.60 | +1.00% | 7.36M | ||
342.07 | 345.54 | 341.30 | -0.22 | -0.06% | 1.26M | ||
168.22 | 169.28 | 168.06 | -0.39 | -0.23% | 1.19M | ||
39.21 | 39.58 | 39.09 | -0.12 | -0.31% | 4.79M | ||
217.04 | 217.50 | 216.41 | +1.13 | +0.52% | 176.54K | ||
148.86 | 149.73 | 148.79 | +0.28 | +0.19% | 2.02M | ||
235.55 | 236.00 | 233.41 | +1.22 | +0.52% | 978.25K | ||
196.97 | 197.19 | 195.03 | +1.97 | +1.01% | 847K | ||
278.31 | 278.88 | 274.07 | +2.68 | +0.97% | 1.63M | ||
276.49 | 276.51 | 272.83 | +3.82 | +1.40% | 2.29M | ||
498.95 | 498.95 | 495.04 | +4.57 | +0.92% | 1.79M | ||
93.39 | 94.32 | 93.22 | +0.03 | +0.03% | 3.54M | ||
165.21 | 166.03 | 164.59 | +0.77 | +0.47% | 3.13M |
Enanta Pharmaceuticals (NASDAQ: NASDAQ:ENTA), a biopharmaceutical company focused on developing oral therapeutics, reported its financial results for the fiscal second quarter...
Microchip Technology Incorporated (NASDAQ:MCHP) has reported its financial results for the fourth quarter and full fiscal year 2024, revealing a decrease in net sales and a...
Microchip Technology Incorporated (NASDAQ:MCHP) has reported its financial results for the fourth quarter and full fiscal year 2024, revealing a decrease in net sales and a...
Disney issued mixed results, and shares fell 5%, but this is a sell-the-news event for dip buyers. Cash flow and FCF exceeded expectations and led the company to increase its...
Monday’s trading session was bullish, with the S&P 500 index gaining 1.03% and closing the highest since April 11. Last Friday, the index gained 1.3% following a 0.9%...
Uber is set to report earnings tomorrow. Investors will be eying revenue figures alongside key metrics like bookings. Can the ride-sharing giant deliver? Invest like the big funds...
Tuesday, May 7, 2024 | ||||||
Duke Energy(DUK) | EPS / Forecast | Revenue / Forecast | 1.44 / 1.38 | 7.67B / 7.31B | ||
McKesson(MCK) | EPS / Forecast | Revenue / Forecast | -- / 6.36 | -- / 79.35B | ||
Equinix(EQIX) | EPS / Forecast | Revenue / Forecast | -- / 2.66 | -- / 2.14B | ||
Occidental(OXY) | EPS / Forecast | Revenue / Forecast | -- / 0.5792 | -- / 6.72B | ||
Datadog(DDOG) | EPS / Forecast | Revenue / Forecast | 0.44 / 0.34 | 611M / 590.65M | ||
Kenvue(KVUE) | EPS / Forecast | Revenue / Forecast | 0.28 / 0.28 | 3.9B / 3.85B | ||
Waters(WAT) | EPS / Forecast | Revenue / Forecast | 2.21 / 2.09 | 637M / 635.57M | ||
Jacobs Engineering(J) | EPS / Forecast | Revenue / Forecast | 1.91 / 1.85 | 4.27B / 4.33B | ||
Jack Henry&Associates(JKHY) | EPS / Forecast | Revenue / Forecast | -- / 1.17 | -- / 541.99M | ||
Match Group(MTCH) | EPS / Forecast | Revenue / Forecast | -- / 0.4098 | -- / 855.79M |